Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03988400 · ClinicalTrials.gov registry record · Early Phase 1
Sensory Augmentation Methods in Stroke
A Early Phase 1 study of Stroke, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 44
- Enrollment target
- 1
- Study location
NCT03988400: Completed Early Phase 1 study of Stroke, sponsored by VA Office of Research and Development.
NCT03988400 is a Early Phase 1 study of Stroke that has completed, run by VA Office of Research and Development. The registered enrollment target is 44 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03988400, a Early Phase 1 study of Stroke, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 44 participants
- Enrollment target
- 1
- Study location
Study Summary
Many chronic stroke survivors have poor walking balance, contributing to an increased risk of falls and fear of falling. One factor contributing to these balance deficits is a reduced ability to place the feet appropriately when walking. This study investigates whether enhancing the sensory information available to chronic stroke survivors while they walk improves their foot placement accuracy and balance.
Primary Outcome
The investigators will monitor the safety of the intervention by quantifying the percentage of participants who experience an adverse event potentially related to the intervention (e.g. skin irritation; falls) or any serious adverse event (e.g. hospitalization; death). This information is gathered through participant self-report, or through communication with participant caregiver if necessary.
Conditions Studied
Interventions
- BEHAVIORAL Sensory Augmentation
- BEHAVIORAL Random Vibration
Study Locations (1)
South Carolina
- Ralph H. Johnson VA Medical Center, Charleston, SC - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2022-04-04 |
| Est. Completion | 2023-04-26 |
| Phase | Early Phase 1 |
What the finished NCT03988400 record still lists
NCT03988400 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 2 interventions - of which Sensory Augmentation is the first listed.
NCT03988400 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT03988400 about?
NCT03988400 is a clinical study titled "Sensory Augmentation Methods in Stroke". Many chronic stroke survivors have poor walking balance, contributing to an increased risk of falls and fear of falling. One factor contributing to these balance deficits is a reduced ability to place the feet appropriately when walking. This study investigates whether enhancing the sensory informat...
What is the current status of trial NCT03988400?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 44 participants. The study started on 2022-04-04. Estimated completion is 2023-04-26.
What conditions does trial NCT03988400 study?
This clinical trial studies the following conditions: Stroke.
What interventions are being tested in trial NCT03988400?
The interventions under investigation include: Sensory Augmentation (BEHAVIORAL), Random Vibration (BEHAVIORAL).
Who is sponsoring clinical trial NCT03988400?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03988400 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03988400's enrollment target sits among peer trials
44 255th of 454 higher than 196 of 454 other Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exercise Primed Stroke Rehabilitation
RECRUITING · Early Phase 1
-
R01.Aim 2.Study 1: IsoReach
RECRUITING · Early Phase 1
-
Effect of Neural Constraints on Movement in Stroke
RECRUITING · Early Phase 1
-
Multisensory Augmentation for Post-stroke Standing Balance
RECRUITING · Early Phase 1
-
Cognition and Motor Learning Post-stroke
RECRUITING · Early Phase 1
-
Chronic Transcutaneous Stimulation to Promote Motor Function and Recovery in Individuals With Paralysis or Paresis
RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI